Consistent with the observations above, erlotinib treatment resulted in a significant inhibition in cell proliferation and viability in the TAZ-overexpressing GBM cells (Figure 6C and 6F), indicating that erlotinib can arrest the cell proliferation and viability induced by TAZ. The gene discussed is WWTR1; the disease is glioblastoma.